Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMID 9626808)

Published in Am J Clin Oncol on June 01, 1998

Authors

S R Patel1, S Vadhan-Raj, M A Burgess, C Plager, N Papadopolous, J Jenkins, R S Benjamin

Author Affiliations

1: Department of Melanoma-Sarcoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Articles citing this

Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A (2007) 2.38

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. J Clin Oncol (2015) 2.19

Primary adrenal leiomyosarcoma: a case report and literature review. Clin Med Oncol (2008) 1.05

Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res (2012) 1.01

Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report. Onco Targets Ther (2016) 0.93

Primary pericardial sarcoma: a case report and a brief review. Cardiol Res Pract (2011) 0.87

Cellular immunotherapy for soft tissue sarcomas. Immunotherapy (2012) 0.86

Role of trabectedin in the treatment of soft tissue sarcoma. Onco Targets Ther (2009) 0.86

An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma. Invest New Drugs (2003) 0.81

Clinical applications of palifermin: amelioration of oral mucositis and other potential indications. J Cell Mol Med (2013) 0.81

Major clinical research advances in gynecologic cancer in 2015. J Gynecol Oncol (2016) 0.81

High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma. Clin Sarcoma Res (2014) 0.80

Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group. Br J Cancer (2004) 0.80

Management of advanced adult soft tissue sarcoma. Sarcoma (2003) 0.79

Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies. Br J Cancer (2006) 0.77

Gemcitabine in combination with paclitaxel for advanced soft-tissue sarcomas. Mol Clin Oncol (2015) 0.76

Patterns of care for patients with advanced soft tissue sarcoma: experience from Australian sarcoma services. Clin Sarcoma Res (2016) 0.75

Immunotherapies in sarcoma: Updates and future perspectives. World J Clin Oncol (2017) 0.75

Targeted therapy for soft tissue sarcomas in adolescents and young adults. Adolesc Health Med Ther (2017) 0.75

Evaluation of dose-intense Ifosfamide, with and without edatrexate, in adults with sarcoma. Sarcoma (1999) 0.75

Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS). Sarcoma (2006) 0.75

Primary pulmonary chondrosarcoma and a fast-growing mass that accidentally mimicked teratoma. J Thorac Dis (2016) 0.75

Osteomalacia as a late metabolic complication of Ifosfamide chemotherapy in young adults: illustrative cases and review of the literature. Sarcoma (2007) 0.75

Update on clinical research and state of the art management of patients with advanced sarcomas and GIST. ESMO Open (2016) 0.75

Articles by these authors

Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01

Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod (2010) 2.65

Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol (2004) 2.63

Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer (1990) 2.56

Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A (1992) 2.41

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32

X-ray diffraction analysis of matrix porin, an integral membrane protein from Escherichia coli outer membranes. J Mol Biol (1983) 2.29

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22

A brief method for assessing expressed emotion in relatives of psychiatric patients. Psychiatry Res (1986) 2.19

Kepler's optical phase curve of the exoplanet HAT-P-7b. Science (2009) 2.18

Sequence of an HLA-DR alpha-chain cDNA clone and intron-exon organization of the corresponding gene. Nature (1982) 2.18

Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17

Revised FDA labeling guideline for theophylline oral dosage forms. Pharmacotherapy (1995) 2.11

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer (1974) 2.10

Information Technology for postgraduate education: survey of facilities and skills in the South West Deanery. Br J Obstet Gynaecol (1999) 2.04

Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med (1989) 2.03

Objective birth data and the prediction of child abuse. Arch Dis Child (1981) 1.91

Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer (2001) 1.89

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol (1997) 1.87

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85

Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol (2012) 1.81

Phase I trial of recombinant interferon gamma in cancer patients. J Clin Oncol (1986) 1.68

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65

Changing clinical picture of non-accidental injury to children. Br Med J (Clin Res Ed) (1983) 1.60

Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg (1990) 1.59

The structure of Bacillus subtilis pectate lyase in complex with calcium. Nat Struct Biol (1994) 1.53

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia. Am J Med (1996) 1.52

Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50

Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med (1974) 1.48

Genomic medicine: who will practice it? A call to open arms. Am J Med Genet (2001) 1.47

Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47

Adriamycin cardiomyopathy--risk factors. Cancer (1977) 1.46

Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45

Metastatic patterns of choroidal melanoma. Cancer (1974) 1.45

Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45

Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet (2005) 1.44

Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol (2010) 1.42

Towards a clinically useful classification of OHSS. Reprod Biomed Online (2009) 1.41

Ovarian hyperstimulation syndrome: an endocrinopathy? Curr Opin Obstet Gynecol (2001) 1.40

Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst (1991) 1.40

Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40

The effect of norepinephrine versus epinephrine on myocardial hemodynamics during CPR. Ann Emerg Med (1989) 1.39

Hib disease must be prevented. Med J Aust (1994) 1.39

Hepatitis A epidemiology in Australia: national seroprevalence and notifications. Med J Aust (2001) 1.38

Combination chemotherapy in adult desmoid tumors. Cancer (1993) 1.36

Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res (1977) 1.36

Two crystal structures of pectin lyase A from Aspergillus reveal a pH driven conformational change and striking divergence in the substrate-binding clefts of pectin and pectate lyases. Structure (1997) 1.35

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34

IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma. Blood (1998) 1.33

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. J Clin Oncol (1998) 1.32

Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients. Am J Med Sci (1976) 1.32

Structural analysis of the 2.8 A model of Xylose isomerase from Actinoplanes missouriensis. Proteins (1988) 1.31

Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer (1999) 1.31

Crystal structure of polygalacturonase from Erwinia carotovora ssp. carotovora. J Biol Chem (1998) 1.30

Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30

Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29

Role of radiotherapy in sarcoma of the breast--a retrospective review of the M.D. Anderson experience. Radiother Oncol (1999) 1.29

Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide. Proc Natl Acad Sci U S A (1985) 1.29

Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies. Antimicrob Agents Chemother (1972) 1.28

A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol (1984) 1.28

Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. Surgery (1994) 1.28

Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27

A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma. Cancer (1989) 1.27

A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin Oncol (1983) 1.27

Doxorubicin-induced congestive heart failure in adults. Cancer (1985) 1.26

Cardiotoxicity in patients receiving transtuzumab (Herceptin): primary toxicity, synergistic or sequential stress, or surveillance artifact? Semin Oncol (1999) 1.25

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer (1993) 1.25

Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25

Transactivation of the p53 oncogene by E1a gene products. Virology (1990) 1.25

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro Oncol (2001) 1.22

Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22

Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int (2009) 1.22

Arginine residues as stabilizing elements in proteins. Biochemistry (1992) 1.21

Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature. Cancer Treat Rep (1977) 1.21

Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA (1988) 1.20

Homoeopathic vaccination. What does it mean? Immunisation Interest Group of the Royal Alexandra Hospital for Children. Med J Aust (1994) 1.20

Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy. J Clin Oncol (1995) 1.20

Outcome of maple syrup urine disease. Arch Dis Child (1982) 1.20

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Nursing in genitourinary medicine: 10 years on from the Monks Report. The membership of GUNA. Genito-Urinary Nurses Association. Int J STD AIDS (1999) 1.19

Pharmacokinetics and metabolism of adriamycin in man. Clin Pharmacol Ther (1973) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate. Aust N Z J Obstet Gynaecol (1995) 1.18